Cargando…
Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
Nanoparticles have unique properties and high design flexibility, which are thought to be safe, site-specific, and efficient drug delivery systems. However, nanoparticles as exogenous materials can provide recognition and be eliminated by the body’s immune system, which considerably restricts their...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941025/ https://www.ncbi.nlm.nih.gov/pubmed/35316443 http://dx.doi.org/10.1186/s11671-022-03673-9 |
_version_ | 1784673021969039360 |
---|---|
author | Zhao, Xuefen Yan, Chao |
author_facet | Zhao, Xuefen Yan, Chao |
author_sort | Zhao, Xuefen |
collection | PubMed |
description | Nanoparticles have unique properties and high design flexibility, which are thought to be safe, site-specific, and efficient drug delivery systems. However, nanoparticles as exogenous materials can provide recognition and be eliminated by the body’s immune system, which considerably restricts their applications. To overcome these drawbacks, natural cell membrane coating method has attracted great attention in the field of drug delivery systems, which can prolong nanoparticles blood circulation time and avoiding the capture as well as elimination by the body immune system. Biomimetic nanoparticles via a top-down approach can avoid the laborious group modified engineering and keep the integrity of cell membrane structure and membrane antigens, which can be endowed with unique properties, such as immune escape, longer blood circulation time, targeting delivery and controlling drugs sustain-release. At the present research, erythrocyte membrane, cancer cell membrane, platelet membrane, lymphocyte membrane and hybrid membrane have been successfully coated into the surface of nanoparticles to achieve biological camouflage. Thus, integrating various kinds of cell membranes and nanoparticles into one system, the biomimetic nanoparticles can inherit unique biofunction and drug delivery properties to exhibit tumor targeting-delivery and antitumor outcomes. In this article, we will discuss the prospects and challenges of some basic cell membrane cloaking nanoparticles as a drug delivery system for cancer therapy. |
format | Online Article Text |
id | pubmed-8941025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-89410252022-04-08 Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy Zhao, Xuefen Yan, Chao Nanoscale Res Lett Nano Review Nanoparticles have unique properties and high design flexibility, which are thought to be safe, site-specific, and efficient drug delivery systems. However, nanoparticles as exogenous materials can provide recognition and be eliminated by the body’s immune system, which considerably restricts their applications. To overcome these drawbacks, natural cell membrane coating method has attracted great attention in the field of drug delivery systems, which can prolong nanoparticles blood circulation time and avoiding the capture as well as elimination by the body immune system. Biomimetic nanoparticles via a top-down approach can avoid the laborious group modified engineering and keep the integrity of cell membrane structure and membrane antigens, which can be endowed with unique properties, such as immune escape, longer blood circulation time, targeting delivery and controlling drugs sustain-release. At the present research, erythrocyte membrane, cancer cell membrane, platelet membrane, lymphocyte membrane and hybrid membrane have been successfully coated into the surface of nanoparticles to achieve biological camouflage. Thus, integrating various kinds of cell membranes and nanoparticles into one system, the biomimetic nanoparticles can inherit unique biofunction and drug delivery properties to exhibit tumor targeting-delivery and antitumor outcomes. In this article, we will discuss the prospects and challenges of some basic cell membrane cloaking nanoparticles as a drug delivery system for cancer therapy. Springer US 2022-03-22 /pmc/articles/PMC8941025/ /pubmed/35316443 http://dx.doi.org/10.1186/s11671-022-03673-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Nano Review Zhao, Xuefen Yan, Chao Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy |
title | Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy |
title_full | Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy |
title_fullStr | Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy |
title_full_unstemmed | Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy |
title_short | Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy |
title_sort | research progress of cell membrane biomimetic nanoparticles for tumor therapy |
topic | Nano Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941025/ https://www.ncbi.nlm.nih.gov/pubmed/35316443 http://dx.doi.org/10.1186/s11671-022-03673-9 |
work_keys_str_mv | AT zhaoxuefen researchprogressofcellmembranebiomimeticnanoparticlesfortumortherapy AT yanchao researchprogressofcellmembranebiomimeticnanoparticlesfortumortherapy |